-
1
-
-
79960551424
-
Effectiveness of switching from antipsychotic polypharmacy to monotherapy
-
Schizophrenia Trials Network
-
Essock SM, Schooler NR, Stroup TS, McEvoy JP, Rojas I, Jackson C, Covell NH; Schizophrenia Trials Network: Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am J Psychiatry 2011; 168:702-708
-
(2011)
Am J Psychiatry
, vol.168
, pp. 702-708
-
-
Essock, S.M.1
Schooler, N.R.2
Stroup, T.S.3
McEvoy, J.P.4
Rojas, I.5
Jackson, C.6
Covell, N.H.7
-
2
-
-
65349112410
-
Antipsychotic combinations vs monotherapy in schizophrenia: A meta-analysis of randomized controlled trials
-
Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S: Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 2009; 35:443-457
-
(2009)
Schizophr Bull
, vol.35
, pp. 443-457
-
-
Correll, C.U.1
Rummel-Kluge, C.2
Corves, C.3
Kane, J.M.4
Leucht, S.5
-
3
-
-
0032982714
-
2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
-
2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 1999; 156:286-293
-
(1999)
Am J Psychiatry
, vol.156
, pp. 286-293
-
-
Kapur, S.1
Zipursky, R.B.2
Remington, G.3
-
5
-
-
11844304940
-
Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
-
DOI 10.1176/appi.ajp.162.1.130
-
Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA: Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2005; 162:130-136 (Pubitemid 40095682)
-
(2005)
American Journal of Psychiatry
, vol.162
, Issue.1
, pp. 130-136
-
-
Josiassen, R.C.1
Joseph, A.2
Kohegyi, E.3
Stokes, S.4
Dadvand, M.5
Paing, W.W.6
Shaughnessy, R.A.7
-
6
-
-
0030691937
-
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study
-
Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, Modai I, Khaikin M, Weizman A: Sulpride augmentation in people with schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled study. Br J Psychiatry 1997; 171:569-573 (Pubitemid 27527329)
-
(1997)
British Journal of Psychiatry
, vol.171
, Issue.DEC.
, pp. 569-573
-
-
Shiloh, R.1
Zemishlany, Z.2
Aizenberg, D.3
Radwan, M.4
Schwartz, B.5
Dorfman-Etrog, P.6
Modai, I.7
Khaikin, M.8
Weizman, A.9
-
7
-
-
67649313808
-
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients
-
Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC: Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. J Clin Psychopharmacol 2009; 29:165-169
-
(2009)
J Clin Psychopharmacol
, vol.29
, pp. 165-169
-
-
Henderson, D.C.1
Fan, X.2
Copeland, P.M.3
Sharma, B.4
Borba, C.P.5
Boxill, R.6
Freudenreich, O.7
Cather, C.8
Evins, A.E.9
Goff, D.C.10
-
8
-
-
72849140996
-
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy
-
Kane JM, Correll CU, Goff DC, Kirkpatrick B, Marder SR, Vester-Blokland E, Sun W, Carson WH, Pikalov A, Assuncão-Talbott S: A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. J Clin Psychiatry 2009; 70:1348-1357
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 1348-1357
-
-
Kane, J.M.1
Correll, C.U.2
Goff, D.C.3
Kirkpatrick, B.4
Marder, S.R.5
Vester-Blokland, E.6
Sun, W.7
Carson, W.H.8
Pikalov, A.9
Assuncão-Talbott, S.10
-
9
-
-
77649122136
-
Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: A population-based nested case-control study
-
Baandrup L, Gasse C, Jensen VD, Glenthoj BY, Nordentoft M, Lublin H, Fink-Jensen A, Lindhardt A, Mortensen PB: Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study. J Clin Psychiatry 2010; 71:103-108
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 103-108
-
-
Baandrup, L.1
Gasse, C.2
Jensen, V.D.3
Glenthoj, B.Y.4
Nordentoft, M.5
Lublin, H.6
Fink-Jensen, A.7
Lindhardt, A.8
Mortensen, P.B.9
-
10
-
-
68949172254
-
11-Year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study)
-
Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J: 11-Year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374:620-627
-
(2009)
Lancet
, vol.374
, pp. 620-627
-
-
Tiihonen, J.1
Lönnqvist, J.2
Wahlbeck, K.3
Klaukka, T.4
Niskanen, L.5
Tanskanen, A.6
Haukka, J.7
-
11
-
-
58349114259
-
Atypical antipsychotic drugs and the risk of sudden cardiac death
-
Ray WA, Chung CP, Murray KT, Hall K, Stein CM: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360:225-235
-
(2009)
N Engl J Med
, vol.360
, pp. 225-235
-
-
Ray, W.A.1
Chung, C.P.2
Murray, K.T.3
Hall, K.4
Stein, C.M.5
-
12
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
-
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209-1223
-
(2005)
N Engl J Med
, vol.353
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
Swartz, M.S.4
Rosenheck, R.A.5
Perkins, D.O.6
Keefe, R.S.7
Davis, S.M.8
Davis, C.E.9
Lebowitz, B.D.10
Severe, J.11
Hsiao, J.K.12
|